Provention Bio, Inc. Uncategorized Contracts & Agreements
12 Contracts & Agreements
- Co-Promotion Agreement, dated October 4, 2022, between Provention Bio, Inc. and Genzyme Corporation (Filed With SEC on March 24, 2023)
- Letter Agreement, dated March 12, 2023, by and between the Company and Thierry Chauche (Filed With SEC on March 13, 2023)
- Letter Agreement, dated March 12, 2023, by and between the Company and Ashleigh Palmer (Filed With SEC on March 13, 2023)
- Letter Agreement, dated March 12, 2023, by and between the Company and Eleanor Ramos (Filed With SEC on March 13, 2023)
- Scientific Advisor Agreement, dated June 1, 2022, between Provention Bio, Inc. and Jeffrey Bluestone (Filed With SEC on June 3, 2022)
- Provention Bio, Inc. 2020 Inducement Plan, as amended (Filed With SEC on May 20, 2022)
- Description of Registrants Securities (Filed With SEC on February 24, 2022)
- Description of Registrants Securities (Filed With SEC on February 25, 2021)
- Description of Registrants Securities (, Exhibit 4.4) (Filed With SEC on March 12, 2020)
- Form of Right of First Refusal and Co-Sale Agreement between Provention and investors for an offering completed on April 25, 2017 (Filed With SEC on May 9, 2018)
- Form of Lock-Up Agreement with MDB Capital Group, LLC (Filed With SEC on May 9, 2018)
- Engagement Agreement dated September 19, 2016, between Provention and MDB Capital Group, LLC (Filed With SEC on May 9, 2018)
